External validation of prognostic scores for COVID-19 : a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature..
PURPOSE: The Coronavirus disease 2019 (COVID-19) has led to an unparalleled influx of patients. Prognostic scores could help optimizing healthcare delivery, but most of them have not been comprehensively validated. We aim to externally validate existing prognostic scores for COVID-19.
METHODS: We used "COVID-19 Evidence Alerts" (McMaster University) to retrieve high-quality prognostic scores predicting death or intensive care unit (ICU) transfer from routinely collected data. We studied their accuracy in a retrospective multicenter cohort of adult patients hospitalized for COVID-19 from January 2020 to April 2021 in the Greater Paris University Hospitals. Areas under the receiver operating characteristic curves (AUC) were computed for the prediction of the original outcome, 30-day in-hospital mortality and the composite of 30-day in-hospital mortality or ICU transfer.
RESULTS: We included 14,343 consecutive patients, 2583 (18%) died and 5067 (35%) died or were transferred to the ICU. We examined 274 studies and found 32 scores meeting the inclusion criteria: 19 had a significantly lower AUC in our cohort than in previously published validation studies for the original outcome; 25 performed better to predict in-hospital mortality than the composite of in-hospital mortality or ICU transfer; 7 had an AUC > 0.75 to predict in-hospital mortality; 2 had an AUC > 0.70 to predict the composite outcome.
CONCLUSION: Seven prognostic scores were fairly accurate to predict death in hospitalized COVID-19 patients. The 4C Mortality Score and the ABCS stand out because they performed as well in our cohort and their initial validation cohort, during the first epidemic wave and subsequent waves, and in younger and older patients.
| Errataetall: |
CommentIn: Intensive Care Med. 2021 Dec;47(12):1472-1474. - PMID 34608529 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:47 |
|---|---|
| Enthalten in: |
Intensive care medicine - 47(2021), 12 vom: 28. Dez., Seite 1426-1439 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Lombardi, Yannis [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 30.11.2021 Date Revised 09.12.2021 published: Print-Electronic CommentIn: Intensive Care Med. 2021 Dec;47(12):1472-1474. - PMID 34608529 Citation Status MEDLINE |
|---|
| doi: |
10.1007/s00134-021-06524-w |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM331268086 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM331268086 | ||
| 003 | DE-627 | ||
| 005 | 20231225213105.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s00134-021-06524-w |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1104.xml |
| 035 | |a (DE-627)NLM331268086 | ||
| 035 | |a (NLM)34585270 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Lombardi, Yannis |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a External validation of prognostic scores for COVID-19 |b a multicenter cohort study of patients hospitalized in Greater Paris University Hospitals |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.11.2021 | ||
| 500 | |a Date Revised 09.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Intensive Care Med. 2021 Dec;47(12):1472-1474. - PMID 34608529 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2021. Springer-Verlag GmbH Germany, part of Springer Nature. | ||
| 520 | |a PURPOSE: The Coronavirus disease 2019 (COVID-19) has led to an unparalleled influx of patients. Prognostic scores could help optimizing healthcare delivery, but most of them have not been comprehensively validated. We aim to externally validate existing prognostic scores for COVID-19 | ||
| 520 | |a METHODS: We used "COVID-19 Evidence Alerts" (McMaster University) to retrieve high-quality prognostic scores predicting death or intensive care unit (ICU) transfer from routinely collected data. We studied their accuracy in a retrospective multicenter cohort of adult patients hospitalized for COVID-19 from January 2020 to April 2021 in the Greater Paris University Hospitals. Areas under the receiver operating characteristic curves (AUC) were computed for the prediction of the original outcome, 30-day in-hospital mortality and the composite of 30-day in-hospital mortality or ICU transfer | ||
| 520 | |a RESULTS: We included 14,343 consecutive patients, 2583 (18%) died and 5067 (35%) died or were transferred to the ICU. We examined 274 studies and found 32 scores meeting the inclusion criteria: 19 had a significantly lower AUC in our cohort than in previously published validation studies for the original outcome; 25 performed better to predict in-hospital mortality than the composite of in-hospital mortality or ICU transfer; 7 had an AUC > 0.75 to predict in-hospital mortality; 2 had an AUC > 0.70 to predict the composite outcome | ||
| 520 | |a CONCLUSION: Seven prognostic scores were fairly accurate to predict death in hospitalized COVID-19 patients. The 4C Mortality Score and the ABCS stand out because they performed as well in our cohort and their initial validation cohort, during the first epidemic wave and subsequent waves, and in younger and older patients | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Cohort studies | |
| 650 | 4 | |a Intensive care units | |
| 650 | 4 | |a Mortality | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a SARS-CoV-2 | |
| 700 | 1 | |a Azoyan, Loris |e verfasserin |4 aut | |
| 700 | 1 | |a Szychowiak, Piotr |e verfasserin |4 aut | |
| 700 | 1 | |a Bellamine, Ali |e verfasserin |4 aut | |
| 700 | 1 | |a Lemaitre, Guillaume |e verfasserin |4 aut | |
| 700 | 1 | |a Bernaux, Mélodie |e verfasserin |4 aut | |
| 700 | 1 | |a Daniel, Christel |e verfasserin |4 aut | |
| 700 | 1 | |a Leblanc, Judith |e verfasserin |4 aut | |
| 700 | 1 | |a Riller, Quentin |e verfasserin |4 aut | |
| 700 | 1 | |a Steichen, Olivier |e verfasserin |4 aut | |
| 700 | 0 | |a AP-HP/Universities/INSERM COVID-19 Research Collaboration AP-HP COVID CDR Initiative |e verfasserin |4 aut | |
| 700 | 1 | |a Ancel, Pierre-Yves |e investigator |4 oth | |
| 700 | 1 | |a Bauchet, Alain |e investigator |4 oth | |
| 700 | 1 | |a Beeker, Nathanael |e investigator |4 oth | |
| 700 | 1 | |a Benoit, Vincent |e investigator |4 oth | |
| 700 | 1 | |a Bey, Romain |e investigator |4 oth | |
| 700 | 1 | |a Bourmaud, Aurélie |e investigator |4 oth | |
| 700 | 1 | |a Bréant, Stéphane |e investigator |4 oth | |
| 700 | 1 | |a Burgun, Anita |e investigator |4 oth | |
| 700 | 1 | |a Carrat, Fabrice |e investigator |4 oth | |
| 700 | 1 | |a Caucheteux, Charlotte |e investigator |4 oth | |
| 700 | 1 | |a Champ, Julien |e investigator |4 oth | |
| 700 | 1 | |a Cormont, Sylvie |e investigator |4 oth | |
| 700 | 1 | |a Dubiel, Julien |e investigator |4 oth | |
| 700 | 1 | |a Duclos, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Esteve, Loic |e investigator |4 oth | |
| 700 | 1 | |a Frank, Marie |e investigator |4 oth | |
| 700 | 1 | |a Garcelon, Nicolas |e investigator |4 oth | |
| 700 | 1 | |a Gramfort, Alexandre |e investigator |4 oth | |
| 700 | 1 | |a Griffon, Nicolas |e investigator |4 oth | |
| 700 | 1 | |a Grisel, Olivier |e investigator |4 oth | |
| 700 | 1 | |a Guilbaud, Martin |e investigator |4 oth | |
| 700 | 1 | |a Hassen-Khodja, Claire |e investigator |4 oth | |
| 700 | 1 | |a Hemery, François |e investigator |4 oth | |
| 700 | 1 | |a Hilka, Martin |e investigator |4 oth | |
| 700 | 1 | |a Jannot, Anne Sophie |e investigator |4 oth | |
| 700 | 1 | |a Lambert, Jerome |e investigator |4 oth | |
| 700 | 1 | |a Layese, Richard |e investigator |4 oth | |
| 700 | 1 | |a Lebouter, Léo |e investigator |4 oth | |
| 700 | 1 | |a Leprovost, Damien |e investigator |4 oth | |
| 700 | 1 | |a Lerner, Ivan |e investigator |4 oth | |
| 700 | 1 | |a Sallah, Kankoe Levi |e investigator |4 oth | |
| 700 | 1 | |a Maire, Aurélien |e investigator |4 oth | |
| 700 | 1 | |a Mamzer, Marie-France |e investigator |4 oth | |
| 700 | 1 | |a Martel, Patricia |e investigator |4 oth | |
| 700 | 1 | |a Mensch, Arthur |e investigator |4 oth | |
| 700 | 1 | |a Moreau, Thomas |e investigator |4 oth | |
| 700 | 1 | |a Neuraz, Antoine |e investigator |4 oth | |
| 700 | 1 | |a Orlova, Nina |e investigator |4 oth | |
| 700 | 1 | |a Paris, Nicolas |e investigator |4 oth | |
| 700 | 1 | |a Rance, Bastien |e investigator |4 oth | |
| 700 | 1 | |a Ravera, Hélène |e investigator |4 oth | |
| 700 | 1 | |a Rozes, Antoine |e investigator |4 oth | |
| 700 | 1 | |a Rufat, Pierre |e investigator |4 oth | |
| 700 | 1 | |a Salamanca, Elisa |e investigator |4 oth | |
| 700 | 1 | |a Sandrin, Arnaud |e investigator |4 oth | |
| 700 | 1 | |a Serre, Patricia |e investigator |4 oth | |
| 700 | 1 | |a Tannier, Xavier |e investigator |4 oth | |
| 700 | 1 | |a Treluyer, Jean-Marc |e investigator |4 oth | |
| 700 | 1 | |a Van Gysel, Damien |e investigator |4 oth | |
| 700 | 1 | |a Varoquaux, Gael |e investigator |4 oth | |
| 700 | 1 | |a Vie, Jill-Jênn |e investigator |4 oth | |
| 700 | 1 | |a Wack, Maxime |e investigator |4 oth | |
| 700 | 1 | |a Wajsburt, Perceval |e investigator |4 oth | |
| 700 | 1 | |a Wassermann, Demian |e investigator |4 oth | |
| 700 | 1 | |a Zapletal, Eric |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Intensive care medicine |d 1993 |g 47(2021), 12 vom: 28. Dez., Seite 1426-1439 |w (DE-627)NLM000234818 |x 1432-1238 |7 nnns |
| 773 | 1 | 8 | |g volume:47 |g year:2021 |g number:12 |g day:28 |g month:12 |g pages:1426-1439 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00134-021-06524-w |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 47 |j 2021 |e 12 |b 28 |c 12 |h 1426-1439 | ||